George A. Eldridge

Insider Reports History

Location
Cambridge, MA
Signature
/s/ George A. Eldridge
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by George A. Eldridge:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aerovate Therapeutics, Inc. Officer Title: Chief Financial Officer and Treasurer Stock Option (Right to Buy) 28,763 $470,850 $16.37 14 Jun 2024 Direct
Aerovate Therapeutics, Inc. Officer Title: Chief Financial Officer and Treasurer Common Stock 5,022 $125,701 $25.03 14 Jun 2024 Direct

Insider Reports Filed by George A. Eldridge

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AVTE Aerovate Therapeutics, Inc. 14 Jun 2024 3 -$343,350 4 Officer Title: Chief Financial Officer and Treasurer 14 Jun 2024, 18:00
AVTE Aerovate Therapeutics, Inc. 10 Apr 2024 4 -$185,341 4 Officer Title: Chief Financial Officer and Treasurer 12 Apr 2024, 18:00
AVTE Aerovate Therapeutics, Inc. 01 Apr 2024 3 -$363,468 4 Officer Title: Chief Financial Officer and Treasurer 03 Apr 2024, 18:00
AVTE Aerovate Therapeutics, Inc. 12 Mar 2024 6 -$93,111 4 Officer Title: Chief Financial Officer and Treasurer 14 Mar 2024, 18:00
AVTE Aerovate Therapeutics, Inc. 07 Mar 2024 11 -$593,708 4 Officer Title: Chief Financial Officer and Treasurer 11 Mar 2024, 18:00
AVTE Aerovate Therapeutics, Inc. 22 Jan 2024 1 $0 4 Officer Title: Chief Financial Officer and Treasurer 24 Jan 2024, 18:00
AVTE Aerovate Therapeutics, Inc. 07 Feb 2023 1 $0 4 Officer 08 Feb 2023, 17:10
AVTE Aerovate Therapeutics, Inc. 09 Dec 2022 8 -$367,299 4 Officer Title: Chief Financial Officer and Treasurer 13 Dec 2022, 17:00
AVTE Aerovate Therapeutics, Inc. 07 Dec 2022 10 -$466,175 4 Officer Title: Chief Financial Officer and Treasurer 09 Dec 2022, 17:00
AVTE Aerovate Therapeutics, Inc. 30 Nov 2022 3 -$1,438 4 Officer Title: Chief Financial Officer and Treasurer 02 Dec 2022, 18:00
AVTE Aerovate Therapeutics, Inc. 23 Nov 2022 3 -$21,349 4 Officer Title: Chief Financial Officer and Treasurer 28 Nov 2022, 16:00
AVTE Aerovate Therapeutics, Inc. 18 Nov 2022 10 -$17,931 4 Officer Title: Chief Financial Officer and Treasurer 22 Nov 2022, 19:00
AVTE Aerovate Therapeutics, Inc. 14 Dec 2021 1 $0 4 Officer Title: Chief Financial Officer and Treasurer 16 Dec 2021, 17:00
AVTE Aerovate Therapeutics, Inc. 29 Jun 2021 0 $0 3 Officer Title: Chief Financial Officer and Treasurer Exhibit 24 - Power of Attorney 29 Jun 2021, 19:39
AVTE Aerovate Therapeutics, Inc. 02 Apr 2021 3 $0 4 Officer Title: Chief Financial Officer and Treasurer 01 Jul 2021, 18:29